CD53 and neoplasm: Tetraspanin function in anti-tumor immunity is further supported by our unpublished findings showing increased tumor growth in CD53−/− mice compared to WT mice using a syngeneic immunogenic tumor model (F. Schaper et al., in preparation), which is in accordance with the impaired anti-tumor immunity observed in CD37−/− mice (62).